JP6210981B2 - セルロース粉末 - Google Patents
セルロース粉末 Download PDFInfo
- Publication number
- JP6210981B2 JP6210981B2 JP2014518741A JP2014518741A JP6210981B2 JP 6210981 B2 JP6210981 B2 JP 6210981B2 JP 2014518741 A JP2014518741 A JP 2014518741A JP 2014518741 A JP2014518741 A JP 2014518741A JP 6210981 B2 JP6210981 B2 JP 6210981B2
- Authority
- JP
- Japan
- Prior art keywords
- cellulose powder
- organic carbon
- less
- cellulose
- pure water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/122—Pulverisation by spraying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/05—Alcohols; Metal alcoholates
- C08K5/053—Polyhydroxylic alcohols
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
- C08K5/098—Metal salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/20—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
- C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/04—Oxycellulose; Hydrocellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014518741A JP6210981B2 (ja) | 2012-05-31 | 2013-05-30 | セルロース粉末 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012124016 | 2012-05-31 | ||
JP2012124016 | 2012-05-31 | ||
JP2014518741A JP6210981B2 (ja) | 2012-05-31 | 2013-05-30 | セルロース粉末 |
PCT/JP2013/065111 WO2013180246A1 (fr) | 2012-05-31 | 2013-05-30 | Poudre de cellulose |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017090401A Division JP6383835B2 (ja) | 2012-05-31 | 2017-04-28 | セルロース粉末 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2013180246A1 JPWO2013180246A1 (ja) | 2016-01-21 |
JP6210981B2 true JP6210981B2 (ja) | 2017-10-11 |
Family
ID=49673433
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014518741A Active JP6210981B2 (ja) | 2012-05-31 | 2013-05-30 | セルロース粉末 |
JP2017090401A Active JP6383835B2 (ja) | 2012-05-31 | 2017-04-28 | セルロース粉末 |
JP2018146056A Pending JP2018172699A (ja) | 2012-05-31 | 2018-08-02 | セルロース粉末 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017090401A Active JP6383835B2 (ja) | 2012-05-31 | 2017-04-28 | セルロース粉末 |
JP2018146056A Pending JP2018172699A (ja) | 2012-05-31 | 2018-08-02 | セルロース粉末 |
Country Status (3)
Country | Link |
---|---|
JP (3) | JP6210981B2 (fr) |
IN (1) | IN2014DN10077A (fr) |
WO (1) | WO2013180246A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017165972A (ja) * | 2012-05-31 | 2017-09-21 | 旭化成株式会社 | セルロース粉末 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5950012B1 (ja) * | 2015-09-17 | 2016-07-13 | 王子ホールディングス株式会社 | 微細繊維状セルロース含有物の製造方法 |
JP6638290B2 (ja) * | 2015-09-30 | 2020-01-29 | 日本製紙株式会社 | 粉末状セルロース |
SG11202106839XA (en) * | 2018-12-27 | 2021-07-29 | Asahi Chemical Ind | Cellulose powder, use thereof, and tablets |
JP6884920B2 (ja) * | 2019-04-02 | 2021-06-09 | 旭化成株式会社 | 錠剤の保存安定性を向上させる方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5420126A (en) * | 1977-07-12 | 1979-02-15 | Asahi Chem Ind Co Ltd | Pharmaceutical composition |
JP3534130B2 (ja) * | 1994-03-01 | 2004-06-07 | 旭化成ケミカルズ株式会社 | 医薬品組成物 |
CN1296387C (zh) * | 2000-07-05 | 2007-01-24 | 旭化成株式会社 | 纤维素粉末 |
US7514552B2 (en) * | 2003-05-30 | 2009-04-07 | Asahi Kasei Chemicals Corporation | Cellulose powder |
JP2005232260A (ja) * | 2004-02-18 | 2005-09-02 | Asahi Kasei Chemicals Corp | セルロース無機化合物多孔質複合粒子 |
CN101203553B (zh) * | 2005-04-22 | 2011-05-18 | 旭化成化学株式会社 | 多孔纤维素聚集体及其成型组合物 |
WO2009157564A1 (fr) * | 2008-06-26 | 2009-12-30 | 旭化成ケミカルズ株式会社 | Composition de cellulose |
JP5430091B2 (ja) * | 2008-07-09 | 2014-02-26 | 旭化成せんい株式会社 | 高吸水性樹脂およびその製造方法 |
EP2589618B1 (fr) * | 2010-06-29 | 2015-12-30 | Asahi Kasei Chemicals Corporation | Particules composites qui contiennent à la fois de la cellulose et un composé inorganique |
CA2837057C (fr) * | 2011-06-06 | 2018-08-28 | Trudell Medical International | Dispositif a pression expiratoire positive oscillante |
WO2013180249A1 (fr) * | 2012-05-31 | 2013-12-05 | 旭化成ケミカルズ株式会社 | Poudre de cellulose |
WO2013180246A1 (fr) * | 2012-05-31 | 2013-12-05 | 旭化成ケミカルズ株式会社 | Poudre de cellulose |
IN2014DN10076A (fr) * | 2012-05-31 | 2015-08-21 | Asahi Kasei Chemicals Corp | |
JP6413940B2 (ja) * | 2015-06-11 | 2018-10-31 | 株式会社デンソー | 運転支援装置 |
-
2013
- 2013-05-30 WO PCT/JP2013/065111 patent/WO2013180246A1/fr active Application Filing
- 2013-05-30 IN IN10077DEN2014 patent/IN2014DN10077A/en unknown
- 2013-05-30 JP JP2014518741A patent/JP6210981B2/ja active Active
-
2017
- 2017-04-28 JP JP2017090401A patent/JP6383835B2/ja active Active
-
2018
- 2018-08-02 JP JP2018146056A patent/JP2018172699A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017165972A (ja) * | 2012-05-31 | 2017-09-21 | 旭化成株式会社 | セルロース粉末 |
JP2018172699A (ja) * | 2012-05-31 | 2018-11-08 | 旭化成株式会社 | セルロース粉末 |
Also Published As
Publication number | Publication date |
---|---|
JP2017165972A (ja) | 2017-09-21 |
WO2013180246A1 (fr) | 2013-12-05 |
JP2018172699A (ja) | 2018-11-08 |
IN2014DN10077A (fr) | 2015-08-21 |
JPWO2013180246A1 (ja) | 2016-01-21 |
JP6383835B2 (ja) | 2018-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6383835B2 (ja) | セルロース粉末 | |
JP6462827B2 (ja) | セルロース粉末 | |
JP6449410B2 (ja) | セルロース粉末 | |
JP5110757B2 (ja) | セルロース粉末 | |
JP4737754B2 (ja) | セルロース粉末 | |
JP5577241B2 (ja) | 崩壊性に優れる加工澱粉粉末及びその製法 | |
EP3228324B1 (fr) | Poudre de succinate d'acétate d'hypermellose | |
JP6928530B2 (ja) | ヒドロキシアルキルアルキルセルロース及びその製造方法並びに固形製剤 | |
JP7332549B2 (ja) | マウントの発生を抑制する方法 | |
JP2012501960A (ja) | 医薬固形製剤 | |
Eraga et al. | Superdisintegrant activity of acid-modified millet starch in diclofenac tablet formulations | |
JP2018083923A (ja) | セルロース分散液、セルロース分散液の製造方法、成形体組成物、成形体、及び成形体組成物の製造方法 | |
JP6832753B2 (ja) | セルロース複合体 | |
US10696751B2 (en) | Solid preparation containing alkyl cellulose and method for producing the same | |
JP2005255617A (ja) | 微粒子状活性成分および多孔質セルロース凝集体含有固形製剤組成物 | |
CN116782888A (zh) | 药物组合物 | |
JP2020094023A (ja) | 賦形剤顆粒、錠剤及び錠剤の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160212 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20160401 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160516 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170308 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170428 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170825 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170912 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6210981 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |